JP Morgan PerkinElmer Reaches Deal for $1.5B Credit Facility The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility. JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings Both investment banks are bullish on the genomic data analysis firm, which went public on the Nasdaq a month ago, raising $234 million in gross proceeds. PerkinElmer Enters $500M Credit Facility The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month. JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Analysts estimated the total addressable market for the San Diego-based next-generation sequencing firm at between $44 billion and $50 billion. Singular Genomics Ups IPO Target to $187M The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation. May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Feb 18, 2021 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan Dec 3, 2020 Twist Bioscience Prices Upsized $300M Public Offering Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 3, 2020 Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations Premium Oct 14, 2020 JP Morgan Rates Invitae Neutral Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Oct 7, 2020 NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent Oct 2, 2020 Pacific Biosciences Upgraded to Overweight by JP Morgan Sep 21, 2020 Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider Premium Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Sep 11, 2020 10x Genomics Prices Upsized $440M Public Offering Sep 9, 2020 10x Genomics to Sell 3.5M Shares in Public Offering Aug 20, 2020 JP Morgan Assigns Overweight Ratings to Thermo Fisher, Qiagen Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.